Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: A proposal for greater coherence in European pharmaceutical legislation
The challenge of providing access to high-priced patented medicines is a global problem affecting all countries. A decade and a half ago the use of flexibilities contained in the World Trade Organization Agreement on Trade Related Aspects of Intellectual Property Rights, in particular compulsory lic...
Main Authors: | Ellen F. M. ‘t Hoen, Pascale Boulet, Brook K. Baker |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-12-01
|
Series: | Journal of Pharmaceutical Policy and Practice |
Subjects: | |
Online Access: | http://dx.doi.org/10.1186/s40545-017-0107-9 |
Similar Items
-
The evolution of regulation of compulsory license in international and Serbian sources of patent law
by: Dudaš Atila
Published: (2013-01-01) -
Legal Nature of Compulsory Licensing under Patent Law: Regulatory Measure or Expropriation?
by: Mirghasem Jafarzade, et al.
Published: (2022-08-01) -
Compulsory Licensing in the Pharmaceutical Market: History and Practice
by: K. Yu. Sasykin
Published: (2022-12-01) -
Prophylaxis and exclusion: compulsory isolation of Hansen's disease patients in São Paulo
by: Yara Nogueira Monteiro
Published: (2003-01-01) -
Risk Assessment of Failures in Generic Drug Development and Approval Procedure under Competitive Generic Drug Therapy and Patent Challenge Exclusivities Provided by the United States Food and Drug Administration
by: Reddy M Vivek, et al.
Published: (2022-03-01)